Immunization

Study findings reveal decreased risk of HZ infection

Good Neighbor Pharmacy customers from rural, suburban, and city areas reflect on the past year and discuss the future of independent pharmacy.

Pharmacists can promote vaccinations to at-risk individuals.

Good Neighbor Pharmacy (GNP) has allocated more than 2 million doses of COVID-19 vaccines to more than 1500 independent pharmacies through its partnership with the Federal Retail Pharmacy Program.

Independent pharmacies can turn this opportunity into a revenue strem

Novavax Incorporation announced on Monday that its combined flu and COVID-19 vaccine elicited working antibodies against the viruses in a preclinical study.

The Centers for Disease Control and Prevention released new findings that reveal the safety of COVID-19 vaccination in pregnant women.

Drug Topics® sat down with Dr. Daniel Streetman, PharmD, to discuss patients with compromised immune systems and reported responses to COVID-19 vaccines and others.

The FDA EUA for the COVID-19 vaccine will remain in effect for those 12 to 15 years of age and for the administration of a third dose.

A study published in JAMA Internal Medicine explained that a first dose reaction to COVID-19 vaccination should not deter people from receiving their second dose.

For children who have either experienced a delay in pertussis vaccination or who haven’t received the recommended number of doses, what is their risk of pertussis? A new study provides answers.

Recombinant zoster vaccine (Shingrix; GlaxoSmithKline) is now also indicated for the prevention of shingles in immunocompromised adults 18 years and older.

Pharmacists can work with their patients to address concerns about vaccinations.

"Patient care doesn't stop with COVID-19"

Johnson & Johnson released a statement providing more information on the risks and benefits of its single-shot COVID-19 vaccine.

Pharmacists reflect on their takeaways from the experience and how to move forward.

Administering pediatric immunizations can be a window of opportunity for pharmacists to demonstrate their value.

This article is sponsored by STChealth. 

In part 2 of our interview, Jason Ausili, PharmD, speaks to the challenges of COVID-19 vaccination processes and dives into technology solutions for these workflow barriers.

There was a marked decline in child and adolescent routine vaccine administration during the COVID-19 pandemic between March and September 2020; these vaccination rates have continued to lag behind.

Novavax’s recombinant nanoparticle protein-based COVID-19 vaccine showed an overall efficacy of 90.4% and 100% efficacy against moderate and severe disease.

Here’s a preview of the featured content to watch for this week on Drug Topics®.

Moderna has filed for FDA emergency use authorization for use of its COVID-19 vaccine in adolescents aged 12 through 17.

The vaccine is indicated to prevent invasive disease and pneumonia caused by 20 Streptococcus pneumoniae serotypes.

Jason Ausili, PharmD, highlights President Biden's expectations for community pharmacies amid the COVID-19 vaccination effort.